menu
    • menu

    Company profile for RHODES PHARMACEUTICALS LP

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    A Specialty Pharmaceutical Company Focused On Controlled Substances, Technically Challenging Products, Intellectual Property and Vertical Integration With Rhodes Technologies’ Active Pharmaceutical Ingredients. Position of competitive advantage through backward and forward integration with independent associated companies Experienced management team with extensive experience in the generic pharmaceutical industry

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    RHODES PHARMACEUTICALS LPUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    498 Washington StreetCoventry, RI 02816
    Telephone
    Telephone
    +1 401-262-9400
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.rhodespharma.com:443/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rhodes’s Generics Maraviroc Receives Approval in US
    Rhodes’s Generics Maraviroc Receives Approval in US

    04 Nov 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216143

    FDA
    04 Nov 2025
    Share Share
    Rhodes' Generic Theophylline Receives Receives Approval in the U.S.
    Rhodes' Generic Theophylline Receives Receives Approval in the U.S.

    11 May 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214113

    FDA
    11 May 2023
    Share Share
    RHODES' Generic Macitentan Receives Approval in the U.S.
    RHODES' Generic Macitentan Receives Approval in the U.S.

    11 Jan 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214112

    FDA
    11 Jan 2023
    Share Share
    Sandoz, Amneal & Rhodes join Teva in generic Adderall shortage as demand spikes
    Sandoz, Amneal & Rhodes join Teva in generic Adderall shortage as demand spikes

    30 Aug 2022

    // Fraiser Kansteiner FIERCEPHARMA

    https://www.fiercepharma.com/manufacturing/sandoz-amneal-and-rhodes-join-teva-adderall-shortage-us-demand-spikes

    Fraiser Kansteiner FIERCEPHARMA
    30 Aug 2022
    Share Share
    Enforcement Report - Week of September 22, 2021
    Enforcement Report - Week of September 22, 2021

    22 Sep 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-22-2021-1632297403.pdf

    FDA
    22 Sep 2021
    Share Share
    Rhodes Pharms's Generic Amphetamine Sulphate Receives Approval in the US
    Rhodes Pharms's Generic Amphetamine Sulphate Receives Approval in the US

    07 Sep 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213852

    FDA
    07 Sep 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search